Literature DB >> 28210773

Validating benefit of biomarker-directed therapy for acute kidney injury: can you have your cake and eat it?

J R Prowle1,2, M Schetz3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28210773     DOI: 10.1007/s00134-017-4710-7

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  9 in total

1.  Application of new acute kidney injury biomarkers in human randomized controlled trials.

Authors:  Chirag R Parikh; Dennis G Moledina; Steven G Coca; Heather R Thiessen-Philbrook; Amit X Garg
Journal:  Kidney Int       Date:  2016-04-23       Impact factor: 10.612

2.  Biomarkers for AKI improve clinical practice: no.

Authors:  Marlies Ostermann; Michael Joannidis
Journal:  Intensive Care Med       Date:  2014-11-12       Impact factor: 17.440

3.  Measurement of AKI biomarkers in the ICU: still striving for appropriate clinical indications.

Authors:  John R Prowle
Journal:  Intensive Care Med       Date:  2015-01-22       Impact factor: 17.440

4.  Classifying AKI by Urine Output versus Serum Creatinine Level.

Authors:  John A Kellum; Florentina E Sileanu; Raghavan Murugan; Nicole Lucko; Andrew D Shaw; Gilles Clermont
Journal:  J Am Soc Nephrol       Date:  2015-01-07       Impact factor: 10.121

5.  Con: ACE Inhibitors Should Be Stopped Prior to Cardiovascular Surgery.

Authors:  Andrew Disque; Jacques Neelankavil
Journal:  J Cardiothorac Vasc Anesth       Date:  2016-01-12       Impact factor: 2.628

6.  Diagnosis of acute kidney injury using functional and injury biomarkers: workgroup statements from the tenth Acute Dialysis Quality Initiative Consensus Conference.

Authors:  Peter A McCullough; Andrew D Shaw; Michael Haase; Josee Bouchard; Sushrut S Waikar; Edward D Siew; Patrick T Murray; Ravindra L Mehta; Claudio Ronco
Journal:  Contrib Nephrol       Date:  2013-05-13       Impact factor: 1.580

Review 7.  Urinary and serum biomarkers for the diagnosis of acute kidney injury: an in-depth review of the literature.

Authors:  Jill Vanmassenhove; Raymond Vanholder; Evi Nagler; Wim Van Biesen
Journal:  Nephrol Dial Transplant       Date:  2012-10-31       Impact factor: 5.992

8.  Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial.

Authors:  Melanie Meersch; Christoph Schmidt; Andreas Hoffmeier; Hugo Van Aken; Carola Wempe; Joachim Gerss; Alexander Zarbock
Journal:  Intensive Care Med       Date:  2017-01-21       Impact factor: 17.440

9.  Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury.

Authors:  Kianoush Kashani; Ali Al-Khafaji; Thomas Ardiles; Antonio Artigas; Sean M Bagshaw; Max Bell; Azra Bihorac; Robert Birkhahn; Cynthia M Cely; Lakhmir S Chawla; Danielle L Davison; Thorsten Feldkamp; Lui G Forni; Michelle Ng Gong; Kyle J Gunnerson; Michael Haase; James Hackett; Patrick M Honore; Eric A J Hoste; Olivier Joannes-Boyau; Michael Joannidis; Patrick Kim; Jay L Koyner; Daniel T Laskowitz; Matthew E Lissauer; Gernot Marx; Peter A McCullough; Scott Mullaney; Marlies Ostermann; Thomas Rimmelé; Nathan I Shapiro; Andrew D Shaw; Jing Shi; Amy M Sprague; Jean-Louis Vincent; Christophe Vinsonneau; Ludwig Wagner; Michael G Walker; R Gentry Wilkerson; Kai Zacharowski; John A Kellum
Journal:  Crit Care       Date:  2013-02-06       Impact factor: 9.097

  9 in total
  2 in total

Review 1.  Focus on acute kidney injury 2017.

Authors:  Miet Schetz; John Prowle
Journal:  Intensive Care Med       Date:  2018-09-05       Impact factor: 17.440

2.  AKI biomarkers are poor discriminants for subsequent need for renal replacement therapy, but do not disqualify them yet.

Authors:  Harm-Jan de Grooth; Jean-Jacques Parienti; Miet Schetz
Journal:  Intensive Care Med       Date:  2018-04-12       Impact factor: 17.440

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.